Annual SG&A
$4.77 M
-$1.20 M-20.07%
31 December 2023
Summary:
CNS Pharmaceuticals annual selling, general & administrative expenses is currently $4.77 million, with the most recent change of -$1.20 million (-20.07%) on 31 December 2023. During the last 3 years, it has risen by +$376.60 thousand (+8.57%). CNSP annual SG&A is now -20.07% below its all-time high of $5.97 million, reached on 31 December 2022.CNSP Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$1.38 M
-$27.70 K-1.96%
30 September 2024
Summary:
CNS Pharmaceuticals quarterly selling, general & administrative expenses is currently $1.38 million, with the most recent change of -$27.70 thousand (-1.96%) on 30 September 2024. Over the past year, it has increased by +$260.60 thousand (+23.20%). CNSP quarterly SG&A is now -35.71% below its all-time high of $2.15 million, reached on 31 December 2022.CNSP Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$299.57 M
-$17.06 M-6.04%
30 September 2024
Summary:
CNS Pharmaceuticals TTM selling, general & administrative expenses is currently -$299.57 million, with the most recent change of -$17.06 million (-6.04%) on 30 September 2024. Over the past year, it has dropped by -$305.38 million (-5252.20%). CNSP TTM SG&A is now -3835.85% below its all-time high of $6.07 million, reached on 31 March 2023.CNSP TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CNSP Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -20.1% | +23.2% | -5252.2% |
| 3 y3 years | +8.6% | +12.0% | -6248.8% |
| 5 y5 years | +454.3% | +270.5% | -10000.0% |
CNSP Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -20.1% | +8.6% | -35.7% | +54.4% | -182.4% | at low |
| 5 y | 5 years | -20.1% | +454.3% | -35.7% | +270.5% | -1106.6% | at low |
| alltime | all time | -20.1% | +454.3% | -35.7% | +842.7% | -3835.8% | at low |
CNS Pharmaceuticals Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $1.38 M(-2.0%) | $5.02 M(+5.5%) |
| June 2024 | - | $1.41 M(+26.7%) | $4.76 M(+5.1%) |
| Mar 2024 | - | $1.11 M(+0.6%) | $4.53 M(-5.1%) |
| Dec 2023 | $4.77 M(-20.1%) | $1.11 M(-1.4%) | $4.77 M(-18.0%) |
| Sept 2023 | - | $1.12 M(-4.8%) | $5.81 M(-1.5%) |
| June 2023 | - | $1.18 M(-13.2%) | $5.90 M(-2.7%) |
| Mar 2023 | - | $1.36 M(-36.9%) | $6.07 M(+1.6%) |
| Dec 2022 | $5.97 M(+27.5%) | $2.15 M(+77.7%) | $5.97 M(+26.7%) |
| Sept 2022 | - | $1.21 M(-9.8%) | $4.71 M(-0.5%) |
| June 2022 | - | $1.34 M(+6.6%) | $4.74 M(+4.3%) |
| Mar 2022 | - | $1.26 M(+40.6%) | $4.54 M(-3.0%) |
| Dec 2021 | $4.68 M | $896.30 K(-27.4%) | $4.68 M(-3.9%) |
| Sept 2021 | - | $1.24 M(+7.8%) | $4.87 M(+5.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2021 | - | $1.15 M(-18.3%) | $4.61 M(+3.7%) |
| Mar 2021 | - | $1.40 M(+29.0%) | $4.44 M(+1.1%) |
| Dec 2020 | $4.39 M(+122.0%) | $1.09 M(+12.3%) | $4.39 M(+0.0%) |
| Sept 2020 | - | $968.80 K(-1.3%) | $4.39 M(+15.7%) |
| June 2020 | - | $981.50 K(-27.6%) | $3.80 M(+19.1%) |
| Mar 2020 | - | $1.36 M(+24.8%) | $3.19 M(+61.1%) |
| Dec 2019 | $1.98 M(+129.9%) | $1.09 M(+190.8%) | $1.98 M(+79.7%) |
| Sept 2019 | - | $373.50 K(+0.3%) | $1.10 M(+23.3%) |
| June 2019 | - | $372.30 K(+153.6%) | $893.00 K(+24.6%) |
| Mar 2019 | - | $146.80 K(-29.6%) | $716.80 K(+25.8%) |
| Dec 2018 | $860.50 K | $208.60 K(+26.2%) | $570.00 K(+57.7%) |
| Sept 2018 | - | $165.30 K(-15.7%) | $361.40 K(+84.3%) |
| June 2018 | - | $196.10 K | $196.10 K |
FAQ
- What is CNS Pharmaceuticals annual selling, general & administrative expenses?
- What is the all time high annual SG&A for CNS Pharmaceuticals?
- What is CNS Pharmaceuticals annual SG&A year-on-year change?
- What is CNS Pharmaceuticals quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for CNS Pharmaceuticals?
- What is CNS Pharmaceuticals quarterly SG&A year-on-year change?
- What is CNS Pharmaceuticals TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for CNS Pharmaceuticals?
- What is CNS Pharmaceuticals TTM SG&A year-on-year change?
What is CNS Pharmaceuticals annual selling, general & administrative expenses?
The current annual SG&A of CNSP is $4.77 M
What is the all time high annual SG&A for CNS Pharmaceuticals?
CNS Pharmaceuticals all-time high annual selling, general & administrative expenses is $5.97 M
What is CNS Pharmaceuticals annual SG&A year-on-year change?
Over the past year, CNSP annual selling, general & administrative expenses has changed by -$1.20 M (-20.07%)
What is CNS Pharmaceuticals quarterly selling, general & administrative expenses?
The current quarterly SG&A of CNSP is $1.38 M
What is the all time high quarterly SG&A for CNS Pharmaceuticals?
CNS Pharmaceuticals all-time high quarterly selling, general & administrative expenses is $2.15 M
What is CNS Pharmaceuticals quarterly SG&A year-on-year change?
Over the past year, CNSP quarterly selling, general & administrative expenses has changed by +$260.60 K (+23.20%)
What is CNS Pharmaceuticals TTM selling, general & administrative expenses?
The current TTM SG&A of CNSP is -$299.57 M
What is the all time high TTM SG&A for CNS Pharmaceuticals?
CNS Pharmaceuticals all-time high TTM selling, general & administrative expenses is $6.07 M
What is CNS Pharmaceuticals TTM SG&A year-on-year change?
Over the past year, CNSP TTM selling, general & administrative expenses has changed by -$305.38 M (-5252.20%)